Background

I am a consultant nephrologist based at the Royal Derby Hospital with quantitative and qualitative research background in cardiovascular risk in chronic kidney disease. 

Scholarship Project Idea

Chronic kidney disease (CKD) is a leading public health problem associated with significant risks of cardiovascular events, end-stage renal failure and premature death. SGLT2-inhibitors substantially reduce these risks in CKD. However, their usages remain low, where studies have highlighted ethnic, gender and socioeconomic inequities. As most of the CKD population are cared for in the primary care setting, I aim to understand the disparities and barriers to SGLT2-inhibitor prescription in CKD among the primary care practitioners, and ultimately develop effective interventions to facilitate equitable medication optimisation in CKD in primary care.